KROS
Keros Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Jasbir S. Seehra
IPO Date
2020-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Keros Therapeutics, Inc.
CEO
Jasbir S. Seehra
IPO Date
2020-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 550 |
| $10.04 |
| 8 Jun 2026 | Farzan Nima | director | S-Sale | Disposed | 2,625 | $10.73 |
| 8 Jun 2026 | Knowles Julius | director | S-Sale | Disposed | 2,625 | $10.73 |
| 5 Jun 2026 | Seth Alpna | director | A-Award | Acquired | 7,142 | $0.00 |
| 5 Jun 2026 | Seth Alpna | director | A-Award | Acquired | 7,433 | $10.50 |
| 5 Jun 2026 | Seth Alpna | director | S-Sale | Disposed | 2,625 | $10.72 |
| 5 Jun 2026 | GRAY MARY ANN | director | A-Award | Acquired | 7,142 | $0.00 |
| 5 Jun 2026 | GRAY MARY ANN | director | A-Award | Acquired | 7,433 | $10.50 |
| 5 Jun 2026 | Farzan Nima | director | A-Award | Acquired | 7,142 | $0.00 |